Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Abeona Therapeutics
ABEO
$309M
| $2.2M | ﹤0.01% |
356,427
+329,179
| +1,208% | +$1.81M |
|
2277
First American
FAF
$6.77B
| $2.2M | ﹤0.01% |
32,008
-5,299
| -14% | -$353K |
|
2278
Ormat Technologies
ORA
$5.76B
| $2.19M | ﹤0.01% |
20,145
-11,737
| -37% | -$1.45M |
|
2279
Unilever
UL
$135B
| $2.19M | ﹤0.01% |
36,381
-147,271
| -80% | -$8.51M |
|
2280
Denali Therapeutics
DNLI
$3.26B
| $2.18M | ﹤0.01% |
84,892
+32,808
| +63% | +$674K |
|
|
ARIS
2281
Aris Mining
ARIS
$3.91B
| $2.18M | ﹤0.01% |
146,079
-75,183
| -34% | -$1.35M |
|
2282
Peabody Energy
BTU
$3.1B
| $2.17M | ﹤0.01% |
93,978
-1,924
| -2% | -$51.1K |
|
2283
Banco Bradesco
BBD
$36.1B
| $2.17M | ﹤0.01% |
625,976
-74,328
| -11% | -$272K |
|
|
CON
2284
Concentra Group Holdings
CON
$4.46B
| $2.16M | ﹤0.01% |
72,769
+36,171
| +99% | +$899K |
|
2285
GATX Corp
GATX
$6.49B
| $2.16M | ﹤0.01% |
12,215
-12,649
| -51% | -$2.3M |
|
2286
Univest Financial
UVSP
$1.16B
| $2.16M | ﹤0.01% |
49,424
+2,139
| +5% | +$83.8K |
|
2287
Douglas Dynamics
PLOW
$917M
| $2.16M | ﹤0.01% |
40,045
+791
| +2% | +$36.5K |
|
2288
Bath & Body Works
BBWI
$3.32B
| $2.16M | ﹤0.01% |
93,352
-125,243
| -57% | -$2.4M |
|
2289
Wendy's
WEN
$1.25B
| $2.15M | ﹤0.01% |
259,695
+20,473
| +9% | +$146K |
|
2290
Richtech Robotics
RR
$383M
| $2.14M | ﹤0.01% |
1,015,657
-214,152
| -17% | -$520K |
|
2291
Appian
APPN
$2.58B
| $2.14M | ﹤0.01% |
93,488
+18,740
| +25% | +$417K |
|
|
MCHPP
2292
Microchip Technology Inc 7.50% Series A Preferred Stock
MCHPP
| $2.14M | ﹤0.01% |
27,862
-4,557
| -14% | -$346K |
|
2293
Herc Holdings
HRI
$4.53B
| $2.13M | ﹤0.01% |
14,853
+3,819
| +35% | +$493K |
|
2294
Ligand Pharmaceuticals
LGND
$6.01B
| $2.13M | ﹤0.01% |
6,727
+719
| +12% | +$169K |
|
2295
Renasant Corp
RNST
$3.69B
| $2.12M | ﹤0.01% |
49,788
-3,185
| -6% | -$129K |
|
2296
1st Source
SRCE
$2.07B
| $2.12M | ﹤0.01% |
25,956
-2,473
| -9% | -$185K |
|
2297
Hycroft Mining Holding Corp
HYMC
$2B
| $2.1M | ﹤0.01% |
89,915
+5,839
| +7% | +$197K |
|
|
SAIL
2298
SailPoint Inc
SAIL
$11.8B
| $2.09M | ﹤0.01% |
143,077
+129,901
| +986% | +$1.77M |
|
|
BLLN
2299
BillionToOne Inc
BLLN
$5.81B
| $2.09M | ﹤0.01% |
17,446
+14,688
| +533% | +$1.34M |
|
2300
Vita Coco
COCO
$3.39B
| $2.09M | ﹤0.01% |
31,563
+32
| +0.1% | +$2.16K |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.